Lapatinib in Gastric Cancer: What Is the LOGiCal Next Step?

Affiliations

Editorial

Yelena Y Janjigian. J Clin Oncol. 2016.

. 2016 Feb 10;34(5):401-3.

doi: 10.1200/JCO.2015.64.2892. Epub 2015 Dec 23.

¹ Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY janjigiy@mskcc.org.

No abstract available

Comment on

Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial.
Hecht JR, Bang YJ, Qin SK, Chung HC, Xu JM, Park JO, Jeziorski K, Shparyk Y, Hoff PM, Sobrero A, Salman P, Li J, Protsenko SA, Wainberg ZA, Buyse M, Afenjar K, Houé V, Garcia A, Kaneko T, Huang Y, Khan-Wasti S, Santillana S, Press MF, Slamon D. Hecht JR, et al. J Clin Oncol. 2016 Feb 10;34(5):443-51. doi: 10.1200/JCO.2015.62.6598. Epub 2015 Nov 30. J Clin Oncol. 2016. PMID: 26628478 Clinical Trial.